What Parallel Fluidics does

Parallel Fluidics is a Boston-based digital manufacturer of custom microfluidic devices that uses a proprietary process called Transition Molding to produce injection-molding-quality parts in production-grade thermoplastics (PMMA, PC, COP, COC) within days rather than the months required by conventional tooling. The platform addresses a well-defined pain point in microfluidic product development, where legacy workflows force designers to use prototype materials such as PDMS or 3D-printed resins and then revalidate the entire device when transitioning to production thermoplastics, typically adding 12–18 months and $100K–$1M in tooling costs. By collapsing that material and process transition into the prototyping phase itself, Parallel Fluidics enables approximately ten design iterations in a 3–5 month window versus one iteration under legacy manufacturing, with custom devices delivered in as few as three days.

The company's product surface spans a custom manufacturing service (upload CAD, receive a dynamic quote, scale from prototypes to hundreds per month on demand) and a Hardware Library of standardized embedded components, including the MV-1 and MV-2 microvalves, a Pipette Interface compatible with Tecan, Opentrons, and Eppendorf liquid handlers, 1/4-28 and Luer Lock ports, and a 250 µL Reservoir, plus a specialized LNP Screening Array for lipid nanoparticle formulation. The business model is hardware sales (custom devices plus catalog components) augmented by design consultation services, all transacted through a direct-to-customer website with no disclosed resellers. Customers span aerospace (NASA), health technology (SiPhox Health), and biotechnology (Xellar, Wainamics, and a stealth biotech startup), indicating horizontal applicability across life sciences, diagnostics, drug discovery, and adjacent research markets.

Commercially, Parallel Fluidics is a privately held, venture-backed company founded in 2017 with 11–50 employees, headquartered in Stoneham/Boston, Massachusetts. It has raised approximately $12.6 million across disclosed rounds in 2021 ($1.8M), 2022 (~$3.82M), and November 2024 ($7M seed led by J2 Ventures with 8VC and Praxis), with stated use of funds directed at platform acceleration, MV-2 commercialization, and hardware and software expansion. Strategic partnerships include a 2026 co-development with materials supplier Covestro on the Maestro point-of-care diagnostic demonstrative device and an ongoing content and engineering-consultation motion targeting microfluidic developers.

Name

Parallel Fluidics

Legal name

Parallel Fluidics, Inc.

Website

https://parallelfluidics.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Parallel Fluidics is a Boston-based digital manufacturer that uses a proprietary Transition Molding process to fabricate custom microfluidic devices in production-grade thermoplastics within days, serving life sciences, diagnostics, drug discovery, and aerospace customers through a direct, on-demand quoting and ordering platform.

Ownership category

akta.pro rank

Product category

Microfluidic Device Manufacturing

NAICS

Measuring, Dispensing, and Other Pumping Equipment Manufacturing (333914)

SIC

Pumps & Pumping Equipment (3561)

akta.pro primary industry

Precision & Micro Injection Molding (IMANAFAH)

akta.pro secondary industry

Custom Injection Molding & Contract Manufacturing (Job Shops/CMs) (IMANAFAJ)

Keywords

• Microfluidic device manufacturing
• Custom microfluidics fabrication
• Lab-on-chip prototyping
• Transition molding services
• Microfluidic hardware components

Headquarters

HQ city

Stoneham

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Custom Microfluidic Device Manufacturing: The company manufactures custom microfluidic devices to customer specifications. Customers upload CAD designs and receive dynamic quotes for device fabrication. The pricing model allows customers to ramp from prototype quantities (few devices) to hundreds per month with a single click, without lengthy and expensive contracts. This is the primary revenue stream.
2. Parallel Hardware Components: Sale of standardized hardware components including microvalves (MV-1, MV-2), pipette interfaces, ports (1/4-28, Luer-lock), and reservoirs. These are sold as catalog items and also incorporated into custom device designs.
3. Design Consultation Services: Engineering team provides design reviews and consultation to evaluate manufacturability and identify potential issues before expensive tooling iterations. This supports the core manufacturing business.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Parallel Fluidics manufactures custom microfluidic devices on demand with a 3-day turnaround using its proprietary Transition Molding process, delivering injection-molding-quality parts in production-grade thermoplastics (PC, PMMA, COP/COC) without traditional tooling. Customers upload CAD designs to receive dynamic quotes, select modular hardware components (microvalves, ports, pipette interfaces, reservoirs) from the Hardware Library, and scale from prototype quantities to hundreds per month. The company also sells standardized catalog hardware components including the MV-1 and MV-2 microvalves and provides design consultation services to support microfluidic device developers.

Product overview

Parallel Fluidics is a digital manufacturer of microfluidic devices offering custom device manufacturing with a 3-day turnaround using proprietary Transition Molding technology. The company provides a Hardware Library of modular components (MV-1 and MV-2 microvalves, Pipette Interface, 1/4-28 Port, Luer Lock Port, and 250 µL Reservoir) that integrate into custom device designs. Their product portfolio includes the LNP Screening Array for drug discovery and genomics applications. The manufacturing platform enables customers to upload CAD designs and receive devices in production-grade thermoplastics (PMMA, PC, COC/COP) without traditional tooling requirements, bridging prototyping and high-volume injection molding.

Differentiator

Problem solved

Functional benefit

Products and services

• Custom Microfluidic Device Manufacturing On-demand contract manufacturing service for custom microfluidic devices with a 3-day turnaround, using proprietary Transition Molding to deliver injection-molding-quality parts in production-grade thermoplastics (PC, PMMA, COP) without traditional tooling. Customers upload CAD designs, receive dynamic quotes, select from a modular hardware library, and scale from prototype quantities to hundreds per month.
• MV-2 Microvalve Latest-generation automatable microvalve product for point-of-care diagnostics and life science applications, enabling automated and precise flow control in microfluidic devices and integrating with the Parallel Fluidics Hardware Library ecosystem.
• MV-1 Microvalve Catalog microvalve for automating flow control in microfluidic devices, sold as a standalone component and incorporated into custom device designs via the Embedded Hardware lineup.
• LNP Screening Array Specialized microfluidic array for lipid nanoparticle (LNP) formulation screening, drug discovery, and genomics applications, designed for high-throughput screening workflows and compatible with automated liquid handlers.
• Pipette Interface Catalog interface for connecting custom microfluidic devices to existing laboratory liquid handlers. Accommodates standard 50 µL, 200 µL, and 1000 µL pipette tips with documented insertion depth specifications for Tecan, Opentrons, and Eppendorf systems, creating leak-free connections up to 1 bar working pressure for automated screening workflows.
• 1/4-28 Port Flat-bottom threaded port compatible with standard 1/4-28 capillary tube fittings, designed for applications requiring minimal dead volume and high pressure tolerance. Dimensions: 8.6 x 8.6 x 8.8 mm.
• Luer Lock Port Conical port for mating with standard male Luer-lock fittings, suitable for soft tubing applications or lower pressure requirements. Dimensions: 6.9 x 7.8 x 8.8 mm.
• 250 µL Reservoir Conical bottom sample reservoir for gravity-driven flow or interfacing with external manifolds, sized to fit within 96-well microplate spacing standards. Working volume: 250 µL. Overall dimensions: 8.7 x 8.7 x 10.0 mm.
• Design Consultation Services Engineering design reviews and consultation services where the engineering team evaluates customer designs for manufacturability and identifies potential issues before expensive tooling iterations, supporting the core manufacturing business.

Quantifiable outcome

• Reduces development timeline from 3-5 months per iteration to 3 days for custom devices
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature5 records

Partnerships

Two partnerships are on record, tiered core and supporting.

• CovestrocoreStrategic or Co-development Partner · 1 January 2026Parallel Fluidics collaborated with Covestro and four other industry partners (Bally Design, Dukane, Hellbender, TactoTek) to develop the Maestro demonstrative device for point-of-care diagnostics. The device combines IMSE technology with Makrolon polycarbonate for improved diagnostic testing.
• Phase Three Product DevelopmentsupportingStrategic or Co-development PartnerPhase Three Product Development, a medical device product development company specializing in IVD devices and microfluidics, co-authored the sterilization guide for microfluidic medical devices with Parallel Fluidics.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• uFluidix: Canadian microfluidic device manufacturer offering custom chip fabrication and prototyping services in polymers. Comparable to Parallel Fluidics as a custom microfluidic contract manufacturer targeting diagnostics and life science applications.
• MiniFAB: Australia-based contract manufacturer specializing in custom microfluidic device fabrication and medical diagnostics components. Highly comparable to Parallel Fluidics as a specialist microfluidic CM offering both prototyping and scaled production for life science customers.
• Dolomite Microfluidics: Part of Blacktrace Holdings, Dolomite designs and manufactures microfluidic components, chips, and instruments for life sciences and diagnostics. Directly comparable as a microfluidic device manufacturer serving similar biotech, pharma, and diagnostics customer segments.

Broad incumbents

• Stratasys: Large incumbent in polymer 3D printing and additive manufacturing serving medical, dental, and industrial customers. Comparable to Parallel Fluidics in serving microfluidics prototyping customers but with a broader additive manufacturing portfolio rather than molding specialization.
• Micronics (part of Sony): Developer of microfluidic and diagnostic cartridge technologies, now operating within Sony's life sciences portfolio. Comparable as a microfluidic device manufacturer serving clinical diagnostics and life sciences with overlapping target customers.
• Formlabs: Leading provider of desktop and industrial SLA 3D printers plus an on-demand manufacturing service (Formlabs Digital Factory). Competes with Parallel Fluidics for microfluidic prototyping customers but through a 3D printing platform rather than a molding process.

Emerging players

• Boston Micro Fabrication (BMF): Specializes in ultra-high-resolution micro 3D printing for microfluidics, MEMS, and medical devices. Comparable to Parallel Fluidics as an alternative rapid-prototyping pathway into microfluidic device production, competing on resolution and feature size rather than molding speed.
• Elvesys: French company building microfluidic flow control systems, instruments, and chips for life sciences. Comparable to Parallel Fluidics in microfluidic components and life science end markets, with overlap on flow control product categories similar to MV-1/MV-2 microvalves.
• Emulate: Organ-on-chip platform company using microfluidic technology for drug discovery and toxicology. Adjacent peer to Parallel Fluidics as a microfluidic-based life sciences company that consumes or could consume microfluidic device manufacturing services.

Others

• Phase Three Product Development: Medical device and IVD product development consultancy co-authoring sterilization guidance with Parallel Fluidics. Comparable as a microfluidic ecosystem partner serving the same diagnostics and IVD customer base, though as a design services firm rather than a manufacturer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Parallel Fluidics